Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesCardiologySummaCare Defibrillator Policy Update | OpenPayer
    Ask Trek AI about this page
    CurrentSummaCarePolicy N/A

    Wearable and Non-wearable Cardioverter Defibrillator Policy

    Customize your policy alerts

    Sign up for all summacare policy alerts

    Know when summacare releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and coverage authorization for wearable and non-wearable automatic cardioverter-defibrillators for SummaCare commercial and Medicare members at high risk for sudden cardiac death. It defines qualifying cardiac conditions, device-specific criteria, limitations, and applicable HCPCS codes.

    Policy Summary
    PayerSummaCare
    PolicyWearable and Non-wearable Cardioverter Defibrillator Policy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateDec 23, 2025
    Last ReviewOct 14, 2025
    Next Review DateN/A
    Key ActionDocument that the member meets the applicable medical-necessity criteria and that the ordering or treating practitioner is experienced in managing patients at risk for sudden cardiac death.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    35%LVEF threshold used in multiple qualifying criteria
    30 secMinimum qualifying sustained ventricular tachyarrhythmia duration
    48 hrPost-acute myocardial infarction period excluded for certain arrhythmias

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    1 yr
    Minimum expected survival in specified exclusion criteria
    K0606 / E0617Primary device codes

    Medical Necessity and Coverage Criteria

    Commercial Members

    Commercial members are eligible when they are at high risk for sudden cardiac death and meet at least one of the following criteria:

    ONE of the following

    • A documented episode of ventricular fibrillation or sustained ventricular tachyarrhythmia lasting 30 seconds or longer, spontaneous or induced during an electrophysiologic (EP) study.
    • A familial or inherited condition with a high risk of life-threatening ventricular tachyarrhythmia, such as long QT syndrome or hypertrophic cardiomyopathy.
    • Documented prior myocardial infarction or dilated cardiomyopathy with measured left ventricular ejection fraction (LVEF) less than or equal to 35%.LVEF ≤ 35%
    • A previously implanted defibrillator requires explantation.
    • An implantable cardioverter-defibrillator cannot be placed because of an infectious process or other temporary condition, such as a waiting period before or following a cardiac event, peripartum cardiomyopathy, recently diagnosed nonischemic cardiomyopathy, awaiting cardiac transplant, or terminal disease with life expectancy of less than 1 year.

    Medicare Wearable Defibrillator — K0606

    For Medicare beneficiaries at high risk for sudden cardiac death, a wearable defibrillator (HCPCS K0606) is covered when at least one of the following criteria is met. The treating practitioner is expected to be experienced in managing beneficiaries at risk for sudden cardiac death.

    ONE of the following

    • A documented episode of ventricular fibrillation or sustained ventricular tachyarrhythmia lasting 30 seconds or longer, spontaneous or induced during an electrophysiologic (EP) study.
    • A familial or inherited condition with a high risk of life-threatening ventricular tachyarrhythmia, such as long QT syndrome or hypertrophic cardiomyopathy.
    • Documented prior myocardial infarction or dilated cardiomyopathy with measured left ventricular ejection fraction (LVEF) less than or equal to 35%.LVEF ≤ 35%
    • A previously implanted defibrillator requires explantation.

    Medicare Nonwearable Defibrillator — E0617

    For Medicare beneficiaries, a nonwearable automatic defibrillator (HCPCS E0617) is covered under either Pathway 1 or Pathway 2.

    Pathway 1 or Pathway 2

    • Pathway 1 — both A and B are required

      • A. ONE of the following conditions

        • A documented episode of cardiac arrest due to ventricular fibrillation, not due to a transient or reversible cause.
        • Sustained ventricular tachyarrhythmia lasting 30 seconds or longer, spontaneous or induced during an electrophysiologic (EP) study, not associated with acute myocardial infarction and not due to a transient or reversible cause.
        • A familial or inherited condition with a high risk of life-threatening ventricular tachyarrhythmia, such as long QT syndrome or hypertrophic cardiomyopathy.
        • Coronary artery disease with prior myocardial infarction — all requirements

    For the commercial and Medicare ventricular-arrhythmia criteria, the qualifying arrhythmia may be spontaneous or induced during an electrophysiologic study. It must not be attributable to a transient or reversible cause. A qualifying sustained ventricular tachyarrhythmia must last at least 30 seconds, and the event must not occur during the first 48 hours of an acute myocardial infarction. For the Medicare nonwearable pathway involving coronary artery disease, the qualifying myocardial infarction and EP study must each precede the external defibrillator prescription by more than 4 weeks.

    Medicare nonwearable automatic defibrillator coverage is excluded when the beneficiary has cardiogenic shock or symptomatic hypotension while in a stable baseline rhythm; underwent CABG or PTCA within the past 3 months; had an enzyme-positive myocardial infarction within the past month; has clinical symptoms or findings that would make the beneficiary a candidate for coronary revascularization; has irreversible brain damage from preexisting cerebral disease; or has a noncardiac disease, including cancer, uremia, or liver failure, associated with a likelihood of survival of less than 1 year.

    Use of wearable cardioverter-defibrillators is considered investigational for all other indications.

    Coding and Clinical Thresholds

    Covered HCPCS CodesHCPCSCovered
    K0606Automatic external defibrillator, with integrated electrocardiogram analysis, garment type
    K0607Replacement battery for automated external defibrillator, each
    K0608Replacement garment for use with automated external defibrillator, each
    K0609Replacement electrodes for use with automated external defibrillator, each
    E0617Non-wearable, automatic external defibrillators with integrated electrocardiogram capability are coded using HCPCS code
    Sustained Ventricular Tachyarrhythmia
    Qualifying duration30 seconds or longer
    Arrhythmia coveredSustained ventricular tachyarrhythmia, spontaneous or induced during an electrophysiologic study
    Key limitationThe arrhythmia must not be due to a transient or reversible cause; certain criteria exclude arrhythmias associated with acute myocardial infarction
    Left Ventricular Ejection Fraction
    Qualifying LVEFLess than or equal to 35%
    Applicable conditionsDocumented prior myocardial infarction, dilated cardiomyopathy, ischemic dilated cardiomyopathy, or nonischemic dilated cardiomyopathy

    Authorization and Documentation Requirements

    Prior Authorization

    Meet Device-Specific Medical Necessity Criteria

    Obtain authorization by documenting that the requested device meets the applicable SummaCare commercial or Medicare medical-necessity criteria. Identify the device and applicable coverage pathway: wearable cardioverter-defibrillator (K0606) or nonwearable automatic defibrillator (E0617).

    • For commercial members, document that the patient is at high risk for sudden cardiac death and meets at least one covered indication.
    • For Medicare beneficiaries, document that the patient meets the applicable CGS CMS LCD L33690 criteria for K0606 or E0617.
    • A wearable defibrillator is investigational for indications other than the specified qualifying criteria.
    Documentation Required

    Use a Qualified Ordering or Treating Practitioner

    The ordering or treating practitioner must be experienced in managing patients or Medicare beneficiaries at risk for sudden cardiac death. Document the responsible practitioner's qualifications and clinical involvement with the request.

    Clinical Background

    Automatic defibrillators monitor cardiac rhythms, detect dysrhythmias, and deliver a defibrillation shock when appropriate without user decision-making. This policy addresses wearable and non-wearable devices for patients at high risk for sudden cardiac death, including those with prior malignant ventricular arrhythmia, inherited arrhythmia syndromes, cardiomyopathy with reduced LVEF, or a temporary inability to receive an implantable cardioverter-defibrillator.

    Device Definitions

    Automatic Defibrillator
    MonitoringMonitors cardiac rhythms
    DetectionDetects dysrhythmias
    TreatmentDelivers a defibrillation shock to the heart when appropriate without user decision-making
    Wearable Cardioverter-Defibrillator
    Device typeAutomatic external defibrillator supplied as a garment
    Integrated capabilityIntegrated electrocardiogram analysis
    HCPCS codeK0606
    Policy Summary
    PayerSummaCare
    PolicyWearable and Non-wearable Cardioverter Defibrillator Policy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateDec 23, 2025
    Last ReviewOct 14, 2025
    Next Review DateN/A
    Key ActionDocument that the member meets the applicable medical-necessity criteria and that the ordering or treating practitioner is experienced in managing patients at risk for sudden cardiac death.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCoding and Clinical ThresholdsAuthorization and Documentation RequirementsClinical BackgroundDevice Definitions
    • Coronary artery disease with a documented prior myocardial infarction, measured LVEF less than or equal to 35%, and inducible, sustained ventricular tachycardia or ventricular fibrillation during an EP study.LVEF ≤ 35%
    • The qualifying myocardial infarction occurred more than 4 weeks before the external defibrillator prescription.> 4 weeks
    • The EP study was performed more than 4 weeks after the qualifying myocardial infarction.> 4 weeks
  1. Documented prior myocardial infarction with measured LVEF less than or equal to 30%.LVEF ≤ 30%
  2. B. None of the following exclusions may apply

    • Cardiogenic shock or symptomatic hypotension while in a stable baseline rhythm.
    • Coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past 3 months.Past 3 months
    • An enzyme-positive myocardial infarction within the past month.Past month
    • Clinical symptoms or findings that would make the beneficiary a candidate for coronary revascularization.
    • Irreversible brain damage from preexisting cerebral disease.
    • A noncardiac disease, such as cancer, uremia, or liver failure, associated with a likelihood of survival of less than 1 year.
  3. Pathway 2 — ONE of the following conditions

    • Ischemic dilated cardiomyopathy, documented prior myocardial infarction, NYHA Class II or III heart failure, and measured LVEF less than or equal to 35%.LVEF ≤ 35%
    • Nonischemic dilated cardiomyopathy present for more than 3 months, NYHA Class II or III heart failure, and measured LVEF less than or equal to 35%.> 3 months; LVEF ≤ 35%
    • Meets one of the preceding criteria 1–7 and has NYHA Class IV heart failure.
  4. Associated requirementsAdditional requirements may include inducible sustained VT or VF, documented myocardial infarction, cardiomyopathy duration, or NYHA heart failure class
    Prior Myocardial Infarction Timing
    Required intervalMore than 4 weeks prior to the external defibrillator prescription
    Applies toCoronary artery disease with documented prior myocardial infarction, LVEF less than or equal to 35%, and inducible sustained VT or VF during an EP study
    DocumentationRecord the myocardial infarction date and confirm that the interval before prescription exceeds 4 weeks
    EP Study Timing
    Required intervalMore than 4 weeks after the qualifying myocardial infarction
    Study requiredElectrophysiologic study demonstrating inducible, sustained ventricular tachycardia or ventricular fibrillation
    Related criterionCoronary artery disease with prior myocardial infarction and measured LVEF less than or equal to 35%
    LVEF for Prior Myocardial Infarction
    Qualifying LVEFLess than or equal to 30%
    Required cardiac historyDocumented prior myocardial infarction
    Criterion distinctionThis threshold applies to the prior myocardial infarction criterion and is more restrictive than the 35% threshold used in other criteria
    Nonischemic Dilated Cardiomyopathy
    Required durationMore than 3 months
    ConditionNonischemic dilated cardiomyopathy
    Additional requirementsNYHA Class II or III heart failure and measured LVEF less than or equal to 35%
    NYHA Heart Failure Class
    Qualifying classesNYHA Class II, III, or IV, as specified by the criterion
    Class II or III criteriaIschemic or nonischemic dilated cardiomyopathy criteria require NYHA Class II or III heart failure
    Class IV criterionNYHA Class IV heart failure qualifies when the beneficiary meets one of the preceding criteria 1 through 7
    • For commercial coverage, the ordering physician is expected to be experienced in managing patients at risk for sudden cardiac death, including when an implanted defibrillator requires explantation.
    • For Medicare coverage, the treating practitioner is expected to be experienced in managing beneficiaries at risk for sudden cardiac death.
    Documentation Required

    Provide Clinical Eligibility Documentation

    Submit clinical records supporting the qualifying diagnosis, arrhythmia history, left ventricular ejection fraction (LVEF), timing of relevant cardiac events or procedures, and applicable heart-failure classification. Records must establish that the qualifying condition is not attributable to a transient or reversible cause when that limitation applies.

    • Document ventricular fibrillation or sustained ventricular tachyarrhythmia lasting at least 30 seconds, whether spontaneous or induced during an electrophysiologic study, as applicable; include that it was not due to a transient or reversible cause and, where applicable, did not occur during the first 48 hours of an acute myocardial infarction.
    • Document familial or inherited high-risk conditions, such as long QT syndrome or hypertrophic cardiomyopathy.
    • Document prior myocardial infarction or dilated cardiomyopathy with LVEF ≤35% for applicable commercial or wearable criteria.
    • For nonwearable coverage, document cardiac arrest due to ventricular fibrillation; qualifying sustained ventricular tachyarrhythmia; coronary artery disease with prior myocardial infarction, LVEF ≤35%, and inducible sustained VT/VF; or prior myocardial infarction with LVEF ≤30%. For the inducible VT/VF pathway, the infarction and EP study must each have occurred more than 4 weeks before the prescription or qualifying assessment.
    • For nonwearable coverage, document ischemic dilated cardiomyopathy with prior MI, NYHA class II or III heart failure, and LVEF ≤35%; or nonischemic dilated cardiomyopathy present for more than 3 months with NYHA class II or III heart failure and LVEF ≤35%. Beneficiaries meeting a prior criterion with NYHA class IV heart failure may also qualify.
    Denial Risk

    Avoid Nonqualifying Indications or Risk Profiles

    Expect denial when the patient does not meet a covered high-risk sudden-cardiac-death indication or when the requested wearable device is used for an indication outside the specified criteria. Do not rely on a qualifying diagnosis alone if the required arrhythmia, LVEF, timing, or other clinical conditions are absent.

    • Commercial criteria include qualifying ventricular arrhythmia, inherited high-risk disease, prior MI or dilated cardiomyopathy with LVEF ≤35%, a previously implanted defibrillator requiring explantation, or inability to place an ICD because of an infectious or other temporary condition.
    • For Medicare wearable coverage, the beneficiary must meet at least one of the specified qualifying criteria; all other wearable-defibrillator indications are investigational.
    • For Medicare nonwearable coverage, the beneficiary must meet either the applicable combined condition pathway or the specified alternative criterion; failure to satisfy the required condition set is nonqualifying.
    Denial Risk

    Screen for Non-Wearable Defibrillator Exclusions

    For a nonwearable automatic defibrillator, screen the record for exclusionary conditions before submitting authorization. Coverage is not supported when a listed exclusion or a competing condition makes the requested device inappropriate under the Medicare criteria.

    • Do not proceed when there is cardiogenic shock or symptomatic hypotension during a stable baseline rhythm.
    • Do not proceed when CABG or percutaneous transluminal coronary angioplasty occurred within the past 3 months, or when an enzyme-positive myocardial infarction occurred within the past month.
    • Do not proceed when clinical symptoms or findings indicate that the beneficiary is a candidate for coronary revascularization.
    • Do not proceed when there is irreversible brain damage from preexisting cerebral disease.
    • Do not proceed when a noncardiac disease, such as cancer, uremia, or liver failure, is associated with a likelihood of survival of less than 1 year.
    Non-wearable Automatic Defibrillator
    Device typeNon-wearable automatic external defibrillator
    Integrated capabilityIntegrated electrocardiogram capability
    HCPCS codeE0617